Ascendis Pharma A/S vs WD 40 Company — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while WD 40 Company trades at $233.59 (market cap $3.13B). The key difference: Ascendis Pharma A/S is far larger — about 5.3× WD 40 Company's market cap, and WD 40 Company pays a 1.75% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | WDFC | |
|---|---|---|
Market Cap | $16.67B | $3.13B |
Sector | Health | Technology |
52-Week High | $277.18 | $264.91 |
52-Week Low | $189.74 | $187.52 |
Enterprise Value | $17.04B | $3.18B |
Dividend Yield | — | 1.75% |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →WD-40 Company is a global marketing organization dedicated to creating 'positive lasting memories' by developing and selling products that solve maintenance and cleaning problems. Built around the legendary WD-40 Multi-Use Product, the company operates an asset-light business model, focusing on brand management and innovation while utilizing a network of contract manufacturers to deliver solutions across the Americas, EIMEA, and Asia-Pacific.
Read more on WDFC →